Natural killer cell- and macrophage mediated discordant guinea pig→rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity

Transplantation

Volumn 70, Issue 1, 2000, Pages 86-93

  Xia, Guliang ^a   Ji, Ping ^a   Rutgeerts, Omer ^a   Waer, Mark ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; GRAFT REJECTION; GUINEA PIG; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTIBODIES, HETEROPHILE; COMPLEMENT SYSTEM PROTEINS; GRAFT REJECTION; GUINEA PIGS; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; MACROPHAGES; MALE; RATS; RATS, NUDE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034662212     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
2. Platt JL. Xenotransplantation: recent progress and current perspective. Curr Opin Immunol 1996; 8: 721.
3. Higgins RM, Bevan DJ. Antibody removal therapy in transplantation. Transplant Rev 1995; 9: 177.
4. Moore FD Jr. The potential clinical applications for inhibition of the serum complement system. Transplant Rev 1994; 8: 22.
5. Bach FH, Winkler H, Ferran C, Hancock WW. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
6. Platt JL, Lin SS, McGregor CG. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
7. Jamieson SW. Xenograft hyperacute rejection: a new model. Transplantation 1974; 17: 533.
8. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
9. Dalmasso AP. The complement system in xenotransplantation. Immunopharmacology 1992; 24: 149.
10. Leventhal JR, Matas AJ, Sun LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
11. Scherrer L, Leventhal JR, Matas AJ, Dalmasso AP. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets. Transplantation 1994; 58: 458.
12. Van de Stadt J, Vendeville B, Weill B, et al. Discordant heart xenografts in the rat: Additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection. Transplantation 1988; 45: 514.
13. Koyamada N, Miyatake T, Candinas D, et al. Apyrase administration prolongs discordant xenograft survival. Transplantation 1996; 62: 1739.
14. Candinas D, Lesnikoski BA, Hancock WW, et al. Inhibition of platelet integrin GPIIbIIa prolongs survival of discordant cardiac xenografts. Transplantation 1996; 62: 1.
15. Jakobs FM, Davis EA, White T, Sanfilippo F, Baldwin WM III. Prolonged discordant xenograft survival by inhibition of the intrinsic coagulation pathway in complement C6-deficient recipients. J Heart Lung Transplant 1998; 17: 306.
16. Davis EA, Lam TT, Qian ZP, Ibrahim S, Baldwin WM, Sanfilippo FP. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival. J Heart Lung Transplant 1995; 14: 973.
17. Leventhal JR, Flores HC, Gruber SA, et al. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 1992; 54: 26.
18. Figueroa J, Fuad SA, Kunjummen BD, Platt JL, Bach FH. Suppression of synthesis of natural antibodies by mycophenolate mofetil (RS-61443): its potential use in discordant xenograft. ing. Transplantation 1993; 55: 1371.
19. Hancock WW, Miyatake T, Koyamada N, et al. Effects of leflunomide and deoxyspergualin in the guinea pig to rat cardiac model of delayed xenograft rejection. Transplantation 1997; 64: 696.
20. Candinas D, Belliveau S, Koyamada N, et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial cell activation during delayed xenograft rejection. Transplantation 1996; 62: 1290.
21. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187.
22. Ji P, Xia GL, Sefrioui H, Rutgeerts O, Segers C, Waer M. Induction of T-independent xenotolerance in a semi-discordant hamster-to-presensitized nude rat model. Transplantation 1999; 68: 130.
23. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
24. Braidley PC, Dunning J, White DGJ, et al. An analysis of xenograft rejection in a guinea pig model. Transplant Proc 1994; 26: 1018.
25. Platt JL, Turman MA, Noreen HJ, Fischel RJ, Bolman RD, Bach FH. An ELISA assay for xenoreactive natural antibodies. Transplantation 1990; 49: 1000.
26. Ballow M, Cochrane CG. Two anti-complement factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol 1969; 103: 944.
27. Xia GL, Ji P, Rutgeerts O, Waer M. Maintenance and reversibility of natural killer cell and T cell-independent B lymphocyte xenotolerance in athymic nude rats. Transplantation 1999; 68: 1181.
28. Lin Y, Vandeputte M, Waer M. Factors involved in rejection of concordant xenografts in complement-deficient rats. Transplantation 1997; 63: 1705.
29. Lin Y, Goebels J, Xia GL, Ji P, Vandeputte M, Waer M. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nature Med 1998; 4: 173.
30. White DJ, Yannoutsos N. Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man. Res Immunol 1996; 147: 88.
31. Robson SC, Schulte E Jr, Bach FH. Factors in xenograft rejection. Ann NY Acad Sci 1999; 875: 261.
32. Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell response. J Immunol 1997; 158: 5658.
33. Rolstad B, Vaage JT, Naper C, et al. Positive- and negative MHC class I recognition by rat NK cells. Immunol Rev 1997; 155: 91.
34. Rolstad B, Seaman WE. Natural killer cells and recognition of MHC class I molecules: new perspective and challenges in immunology. Scand J Immunol 1998; 47: 412.
35. Torgerson KM, Salcedo M, Vaage JT, et al. Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells. Transplantation 1997; 63: 119.
36. Seebach JD, Waneck GL. Natural killer cells in xenotransplantation. Xenotranslantation 1997; 4: 201.
37. Manilay JO, Sykes M. Natural killer cells and their role in graft rejection. Curr Opin Immunol 1998; 10: 532.
38. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JB, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 1416.
39. Goodman D, Von Albertini M, Wilson A, Milan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61: 763.
40. Sharabi Y, Aksentijevichi I, Sundt TM, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a non-lethal preparative regimen. J Exp Med 1990; 172: 195.
41. Gourlay WA, Chambers WH, Monaco AP, Maki T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727.
42. Cook JL, Ikle DN, Routes BA. Natural killer cell ontogeny in the athymic rat: relationship between functional maturation and acquired resistance to E1A oncogene-expressing sarcoma cells. J Immunol 1995; 155: 5512.
43. Raulet DH. Development and tolerance of natural killer cells. Curr Opin Immunol 1999; 11: 129.
44. Sentman CL, Olsson MY, Karre K. Missing self recognition by natural killer cells in MHC class I transgeneic mice. A "receptor calibration" model for how effector cells adapt to self. Semin Immunol 1995; 7: 109.
45. Xia GL, Ji P, Rutgeerts O, Vandeputte M, Waer M. Immunomodulatory effects of pretransplant donor blood transfusion on T cell-independent xenoreactive immunity. Transplantation 2000; 69: 1695.
46. Sasaki H, Xu XC, Smith DM, Howard T, Mohanakumar T. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 1999; 67: 31.
47. Munz C, Holmes N, King A, et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185: 385.
48. Seebach JD, Comrack C, Germana S, LeDuern C, Sachs DH derSimonian H. HLA-cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3635.
49. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997; 155: 41.
50. Land W, Sebald R, Grabs G, Brendel W. Prolongation of rabbit xenograft survival with antimacrophage serum in rats. Eur Surg Res 1971; 3: 28.
51. Lotzova E, Gallagher MT, Trentin JJ. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica. Biomedicine 1975; 22: 387.
52. Lazar G Jr, Farkas G, Csanadi J, Lazar G. Gadolinium chloride-induced macrophage blockade prevents rejection of human insulinoma cell xenograft in rats. Transplantation 1997; 63: 729.
53. Fryer JP, Leventhal JR, Dalmasso AP, et al. Beyond hyperacute rejection Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995; 59: 171.
54. 4+ macrophage and not a T lymphocyte. Transplantation 1995; 60: 594.
55. Fox A, Koulmanda M, Mandel TE, van Rooijen N, Harrison LC. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 1998; 66: 1407.
56. Gallily R Stain I, Kornfeld S. Nonimmune nonactivated chicken macrophages destroy murine fibroblasts. Dev Comp Immunol 1985; 9: 691.
57. Lin Y, Vandeputte M, Waer M. Contribution of activated macrophages to the process of delayed xenograft rejection. Transplantation 1997; 64: 1677.
58. Hancock WW. Delayed xenograft rejection. World J Surg 1997; 21: 917.
59. Fryer JP, Chen S, Johnson E, et al. The role of monocytes and macrophages in delayed xenograft rejection. Xenotransplantation 1997; 4: 40.
60. Kwiatkowski P, Artrip JH, Ankersmit J, et al. Importance of CD49d-VCAm interactions in human monocyte adhesion to porcine endothelium. Xenotransplantation 1998; 5: 67.
61. Momoi T, Nakajima K, Sakakibara K, Nagai Y. Localization of a glycosphingolipid, asialo GM1, in rat immunocytes. J Biochem 1982; 91: 301.